IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 121 filers reported holding IMMUNOVANT INC in Q4 2021. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $239,290,475 | +130.7% | 6,233,146 | +14.0% | 0.01% | +200.0% |
Q2 2023 | $103,739,646 | +30.0% | 5,468,616 | +6.3% | 0.00% | 0.0% |
Q1 2023 | $79,778,926 | -11.3% | 5,143,709 | +1.5% | 0.00% | 0.0% |
Q4 2022 | $89,976,862 | +303.1% | 5,069,119 | +26.7% | 0.00% | +100.0% |
Q3 2022 | $22,322,000 | +43.1% | 4,000,450 | +0.0% | 0.00% | – |
Q2 2022 | $15,597,000 | -24.8% | 3,999,493 | +6.2% | 0.00% | – |
Q1 2022 | $20,750,000 | -36.5% | 3,765,713 | -1.8% | 0.00% | -100.0% |
Q4 2021 | $32,667,000 | +0.3% | 3,834,119 | +2.3% | 0.00% | 0.0% |
Q3 2021 | $32,581,000 | -23.0% | 3,749,286 | -6.3% | 0.00% | 0.0% |
Q2 2021 | $42,288,000 | -34.0% | 4,000,697 | +0.1% | 0.00% | -50.0% |
Q1 2021 | $64,107,000 | -64.2% | 3,996,720 | +3.0% | 0.00% | -60.0% |
Q4 2020 | $179,150,000 | +60.1% | 3,878,549 | +21.9% | 0.01% | +25.0% |
Q3 2020 | $111,927,000 | +172.0% | 3,180,644 | +88.2% | 0.00% | +300.0% |
Q2 2020 | $41,155,000 | – | 1,690,114 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alpine Global Management, LLC | 3,007,000 | $25,620,000 | 3.77% |
Deep Track Capital, LP | 4,775,000 | $40,683,000 | 2.87% |
Octagon Capital Advisors LP | 572,862 | $4,881,000 | 0.95% |
Eventide Asset Management | 4,950,000 | $42,174,000 | 0.54% |
WITTENBERG INVESTMENT MANAGEMENT, INC. | 140,500 | $1,197,000 | 0.44% |
FRAZIER MANAGEMENT LLC | 585,759 | $4,991,000 | 0.38% |
MANGROVE PARTNERS IM, LLC | 688,000 | $5,862,000 | 0.35% |
BCK CAPITAL MANAGEMENT LP | 54,293 | $463,000 | 0.31% |
EcoR1 Capital, LLC | 1,140,819 | $9,720,000 | 0.31% |
MANGROVE PARTNERS IM, LLC | 570,400 | $4,860,000 | 0.29% |